Quiet on the insider front: nobody at Arcturus Therapeutics Holdings Inc. bought or sold ARCT shares with their own money this past year.
No open-market insider buying or selling in the last full quarter. Insiders bought in 1 of the last 7 full quarters. Big money check: 135 institutions held ARCT as of Q2 2026, and more funds bought than sold.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Aug 20, 2025 | SASSINE ANDY | CFO | Buy | 1,238 | $16.56 | $21K | SEC |
| Aug 19, 2025 | SASSINE ANDY | CFO | Buy | 1,238 | $16.56 | $21K | SEC |
| Oct 16, 2024 | Chivukula Pad | COO | Sell | 12,000 | $20.76 | $249K | SEC |
| Jun 14, 2024 | SASSINE ANDY | CFO | Sell | 50,000 | $32.03 | $1.6M | SEC |
| Jun 7, 2024 | Chivukula Pad | COO | Sell | 114 | $45.00 | $5K | SEC |
| Jun 4, 2024 | Chivukula Pad | COO | Sell | 26,000 | $40.01 | $1.0M | SEC |
| Mar 27, 2024 | Chivukula Pad | COO | Sell | 17,435 | $35.02 | $611K | SEC |
| Mar 21, 2024 | Chivukula Pad | COO | Sell | 8,565 | $35.01 | $300K | SEC |
| Nov 3, 2023 | Chivukula Pad | COO | Sell | 5,000 | $18.72 | $94K | SEC |
| Oct 4, 2023 | Chivukula Pad | COO | Sell | 5,000 | $25.61 | $128K | SEC |
| Sep 5, 2023 | Chivukula Pad | COO | Sell | 5,000 | $31.45 | $157K | SEC |
| Aug 3, 2023 | Chivukula Pad | COO | Sell | 5,000 | $34.91 | $175K | SEC |
| Jul 18, 2023 | Chivukula Pad | COO | Sell | 25,000 | $35.01 | $875K | SEC |
| Jul 18, 2023 | Kummerfeld Keith C | Officer | Sell | 6,968 | $35.00 | $244K | SEC |
| Jul 7, 2023 | Chivukula Pad | COO | Sell | 5,000 | $28.75 | $144K | SEC |
There were no open-market insider trades in ARCT in the last 12 months. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
135 investment managers reported holding ARCT in SEC Form 13F filings for Q2 2026.
No congressional trades in ARCT were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).